Cyclo Therapeutics, Inc. (CYTH)
0.721
0.00 (0.00%)
Inactive · Last trade price
on Mar 26, 2025
Cyclo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -24.8 | -20.06 | -15.45 | -14.29 | -8.94 | -7.53 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | - | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 1.07 | 0.74 | 0.51 | 0.47 | 0.27 | 0.44 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 0.01 | 0.02 | 0 | - | Upgrade
|
| Other Operating Activities | 2.23 | 0.05 | -0.16 | - | - | -0 | Upgrade
|
| Change in Accounts Receivable | 0.12 | -0.07 | 0.43 | -0.44 | 0.07 | -0.06 | Upgrade
|
| Change in Inventory | -0.08 | -0.05 | -0.03 | 0.01 | 0 | 0.16 | Upgrade
|
| Change in Accounts Payable | -0.6 | 3.25 | -0.2 | 0.41 | 0.14 | 1.12 | Upgrade
|
| Change in Other Net Operating Assets | -0.48 | -0.06 | -0.25 | -1.2 | -0.1 | -0.73 | Upgrade
|
| Operating Cash Flow | -22.52 | -16.19 | -15.11 | -15.01 | -8.54 | -6.59 | Upgrade
|
| Capital Expenditures | -0 | -0 | -0.02 | -0.02 | -0.05 | -0 | Upgrade
|
| Investing Cash Flow | -0 | -0 | 0.04 | 0.01 | -0.01 | 0.04 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.16 | - | Upgrade
|
| Total Debt Issued | 10 | - | - | - | 0.16 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.01 | -0.01 | - | - | Upgrade
|
| Total Debt Repaid | - | - | -0.01 | -0.01 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 10 | - | -0.01 | -0.01 | 0.16 | - | Upgrade
|
| Issuance of Common Stock | 2.9 | 12.13 | - | 18.76 | 17.47 | 7.57 | Upgrade
|
| Other Financing Activities | 8.75 | 11.76 | 0.01 | - | 0.98 | -0.45 | Upgrade
|
| Financing Cash Flow | 21.65 | 23.89 | 0.01 | 18.76 | 18.62 | 7.12 | Upgrade
|
| Net Cash Flow | -0.87 | 7.7 | -15.07 | 3.77 | 10.06 | 0.57 | Upgrade
|
| Free Cash Flow | -22.52 | -16.19 | -15.13 | -15.03 | -8.59 | -6.59 | Upgrade
|
| Free Cash Flow Margin | -2586.35% | -1503.84% | -1099.71% | -947.67% | -951.24% | -654.37% | Upgrade
|
| Free Cash Flow Per Share | -0.83 | -0.99 | -1.79 | -2.36 | -5.37 | -6.09 | Upgrade
|
| Cash Interest Paid | 0 | 0.01 | - | 0 | 0 | - | Upgrade
|
| Levered Free Cash Flow | -13.05 | -8.26 | -9.23 | -9.95 | -4.98 | -3.68 | Upgrade
|
| Unlevered Free Cash Flow | -13.05 | -8.26 | -9.23 | -9.95 | -4.98 | -3.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.